Hydroxyurea
98%
- Product Code: 80147
Alias:
Hydroxyurea; Hydroxyurea, Carbamoyl Hydroxylamine, Carbamoyl Hydroxylamine
CAS:
127-07-1
| Molecular Weight: | 76.05 g./mol | Molecular Formula: | CH₄N₂O₂ |
|---|---|---|---|
| EC Number: | 204-821-7 | MDL Number: | MFCD00007943 |
| Melting Point: | 135-140 °C | Boiling Point: | |
| Density: | Storage Condition: | 2~8°C |
Product Description:
Hydroxyurea is primarily used in the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and some forms of head and neck cancer. It works by slowing down the growth of cancer cells, allowing the body to manage the disease more effectively. Additionally, it is employed in the management of sickle cell anemia, where it helps reduce the frequency of painful crises and the need for blood transfusions by increasing the production of fetal hemoglobin. In polycythemia vera, a condition characterized by an overproduction of red blood cells, hydroxyurea helps to lower the number of blood cells, reducing the risk of complications like blood clots. It is also used in some cases of HIV/AIDS as part of combination therapy to enhance the effectiveness of antiviral medications. The drug is administered orally and requires careful monitoring to manage potential side effects and ensure optimal therapeutic outcomes.
Product Specification:
| Test | Specification |
|---|---|
| LOSE ON DRYING | 0-0.01 |
| MELTING POINT | 142-146 |
| Purity | 98-100 |
| APPEARANCE | White to off-white powder |
| INFRARED SPECTRUM | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿300.00 |
+
-
|
| 5.000 | 10-20 days | ฿390.00 |
+
-
|
| 25.000 | 10-20 days | ฿490.00 |
+
-
|
| 100.000 | 10-20 days | ฿1,190.00 |
+
-
|
| 500.000 | 10-20 days | ฿5,070.00 |
+
-
|
Hydroxyurea
Hydroxyurea is primarily used in the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and some forms of head and neck cancer. It works by slowing down the growth of cancer cells, allowing the body to manage the disease more effectively. Additionally, it is employed in the management of sickle cell anemia, where it helps reduce the frequency of painful crises and the need for blood transfusions by increasing the production of fetal hemoglobin. In polycythemia vera, a condition characterized by an overproduction of red blood cells, hydroxyurea helps to lower the number of blood cells, reducing the risk of complications like blood clots. It is also used in some cases of HIV/AIDS as part of combination therapy to enhance the effectiveness of antiviral medications. The drug is administered orally and requires careful monitoring to manage potential side effects and ensure optimal therapeutic outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :